| 发明名称 |
ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
| 摘要 |
The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases. |
| 申请公布号 |
US2016106763(A1) |
申请公布日期 |
2016.04.21 |
| 申请号 |
US201414893902 |
申请日期 |
2014.06.05 |
| 申请人 |
FERRER INTERNACIONAL, S.A. ;FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III |
发明人 |
MARTIN SANZ Pablo;URBANO HURTADO Javier |
| 分类号 |
A61K31/616;A61K9/48;A61K31/403;A61K9/28;A61K31/505;A61K31/40 |
主分类号 |
A61K31/616 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Barcelona ES |
